Evidence map›Paper›PMID 38196823›Full record

ArticleIEEE journal of translational engineering in health and medicine2024

A Wearable Fluorescence Imaging Device for Intraoperative Identification of Human Brain Tumors.

Mehrana Mohtasebi, Chong Huang, Mingjun Zhao, Siavash Mazdeyasna, Xuhui Liu, Samaneh Rabienia Haratbar, Faraneh Fathi, Jinghong Sun, Thomas Pittman, Guoqiang Yu

Open access · goldAbstract read
In one paragraph

Article in IEEE journal of translational engineering in health and medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Mehrana MohtasebiDepartment of Biomedical EngineeringUniversity of Kentucky Lexington KY 40506 USA.ORCID 0000-0002-4689-990X
Chong HuangDepartment of Biomedical EngineeringUniversity of Kentucky Lexington KY 40506 USA.ORCID 0000-0002-5260-9112
Mingjun ZhaoDepartment of Biomedical EngineeringUniversity of Kentucky Lexington KY 40506 USA.ORCID 0000-0002-8657-4413
Siavash MazdeyasnaDepartment of Biomedical EngineeringUniversity of Kentucky Lexington KY 40506 USA.ORCID 0000-0001-5683-9866
Xuhui LiuDepartment of Biomedical EngineeringUniversity of Kentucky Lexington KY 40506 USA.
Samaneh Rabienia HaratbarDepartment of Biomedical EngineeringUniversity of Kentucky Lexington KY 40506 USA.ORCID 0009-0005-3051-2888
Faraneh FathiDepartment of Biomedical EngineeringUniversity of Kentucky Lexington KY 40506 USA.
Jinghong SunBioptics Technology LLC Lexington KY 40506 USA.
Thomas PittmanDepartment of NeurosurgeryUniversity of Kentucky Lexington KY 40506 USA.
Guoqiang YuDepartment of Biomedical EngineeringUniversity of Kentucky Lexington KY 40506 USA.
University of Kentucky · US

Funding

Noninvasive Noncontact High-Density Optical Imaging of Neonatal Intraventricular HemorrhageR01HD101508 · NICHD · UNIVERSITY OF KENTUCKY · PI YU, GUOQIANG · 2020 to 2024
$2.7M
Time-resolved laser speckle contrast imaging of resting-state functional connectivity in neonatal brainR42MH135825 · NIMH · BIOPTICSTECHNOLOGY, LLC · PI YU, GUOQIANG · 2023 to 2025
$2.1M
Development of a Wearable Fluorescence Imaging Device for IntraoperativeIdentification of Brain TumorsR42CA243600 · NCI · BIOPTICSTECHNOLOGY, LLC · PI YU, GUOQIANG · 2023 to 2025
$2.0M
Perioperative Diffuse Optical Imaging of Tissue Blood Flow and Oxygenation for Optimization of Mastectomy Skin Flap ViabilityR01EB028792 · NIBIB · UNIVERSITY OF KENTUCKY · PI YU, GUOQIANG · 2020 to 2024
$1.9M
High-density optical tomography of cerebral blood flow and metabolism in small animalsR41NS122722 · NINDS · BIOPTICSTECHNOLOGY, LLC · PI YU, GUOQIANG · 2021 to 2022
$688k
A Multiscale Multimodal Diffuse Optical Device for Early Detection of Preclinical Alzheimer’s DiseaseR21HD091118 · NICHD · UNIVERSITY OF KENTUCKY · PI YU, GUOQIANG · 2018 to 2019
$568k
Development of a Wearable Fluorescence Imaging Device for Intraoperative Identification of Brain TumorsR41CA243600 · NCI · BIOPTICSTECHNOLOGY, LLC · PI YU, GUOQIANG · 2019 to 2019
$210k
NCI NIH HHS R41 CA243600NCI NIH HHS R42 CA243600NIBIB NIH HHS R01 EB028792NICHD NIH HHS R01 HD101508NICHD NIH HHS R21 HD091118NIMH NIH HHS R42 MH135825NINDS NIH HHS R41 NS122722
6 · The paper itself

Abstract

Malignant glioma (MG) is the most common type of primary malignant brain tumors. Surgical resection of MG remains the cornerstone of therapy and the extent of resection correlates with patient survival. A limiting factor for resection, however, is the difficulty in differentiating the tumor from normal tissue during surgery. Fluorescence imaging is an emerging technique for real-time intraoperative visualization of MGs and their boundaries. However, most clinical grade neurosurgical operative microscopes with fluorescence imaging ability are hampered by low adoption rates due to high cost, limited portability, limited operation flexibility, and lack of skilled professionals with technical knowledge. To overcome the limitations, we innovatively integrated miniaturized light sources, flippable filters, and a recording camera to the surgical eye loupes to generate a wearable fluorescence eye loupe (FLoupe) device for intraoperative imaging of fluorescent MGs. Two FLoupe prototypes were constructed for imaging of Fluorescein and 5-aminolevulinic acid (5-ALA), respectively. The wearable FLoupe devices were tested on tumor-simulating phantoms and patients with MGs. Comparable results were observed against the standard neurosurgical operative microscope (PENTERO® 900) with fluorescence kits. The affordable and wearable FLoupe devices enable visualization of both color and fluorescence images with the same quality as the large and expensive stationary operative microscopes. The wearable FLoupe device allows for a greater range of movement, less obstruction, and faster/easier operation. Thus, it reduces surgery time and is more easily adapted to the surgical environment than unwieldy neurosurgical operative microscopes. Clinical and Translational Impact Statement-The affordable and wearable fluorescence imaging device developed in this study enables neurosurgeons to observe brain tumors with the same clarity and greater flexibility compared to bulky and costly operative microscopes.

Indexed as

Brain NeoplasmsGliomaAminolevulinic AcidColoring AgentsHumansOptical ImagingAminolevulinic AcidColoring AgentsFluorescence guided surgerymalignant gliomaneurosurgical operative microscopewearable fluorescence imaging device

Identifiers

PMID38196823
PMCPMC10776094
OpenAlexW4389252614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.